Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort
Author
Abstract
Suggested Citation
DOI: 10.1371/journal.pone.0023946
Download full text from publisher
References listed on IDEAS
- Boris Augurzky & Silja Göhlmann & Stefan Greß & Jürgen Wasem, 2009. "Effects of the German reference drug program on ex‐factory prices of prescription drugs: a panel data approach," Health Economics, John Wiley & Sons, Ltd., vol. 18(4), pages 421-436, April.
- John Rizzo & Richard Zeckhauser, 2009.
"Generic script share and the price of brand-name drugs: the role of consumer choice,"
International Journal of Health Economics and Management, Springer, vol. 9(3), pages 291-316, September.
- Rizzo, John & Zeckhauser, Richard Jay, 2012. "Generic Script Share and the Price of Brand-Name Drugs: The Role of Consumer Choice," Scholarly Articles 8057977, Harvard Kennedy School of Government.
- Stargardt, Tom & Schreyögg, Jonas & Busse, Reinhard, 2007. "Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany," Health Policy, Elsevier, vol. 84(1), pages 30-38, November.
- J.-Matthias Schulenburg, 2005. "German health care system in transition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(2), pages 183-187, June.
- Jörgen Hellström & Niklas Rudholm, 2004. "Side effects of generic competition?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(3), pages 203-208, September.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Bate, Roger & Jin, Ginger Zhe & Mathur, Aparna, 2011.
"Does price reveal poor-quality drugs? Evidence from 17 countries,"
Journal of Health Economics, Elsevier, vol. 30(6), pages 1150-1163.
- Roger Bate & Ginger Zhe Jin & Aparna Mathur, 2011. "Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries," NBER Working Papers 16854, National Bureau of Economic Research, Inc.
- Aysegul Timur & Gabriel Picone & Jeffrey DeSimone, 2011.
"Has the European union achieved a single pharmaceutical market?,"
International Journal of Health Economics and Management, Springer, vol. 11(4), pages 223-244, December.
- Aysegul Timur & Gabriel Picone & Jeffrey S. DeSimone, 2010. "Has the European Union Achieved a Single Pharmaceutical Market?," NBER Working Papers 16261, National Bureau of Economic Research, Inc.
- Stock, Stephanie Anja Katharina & Redaelli, Marcus & Lauterbach, Karl Wilhelm, 2007. "Disease management and health care reforms in Germany--Does more competition lead to less solidarity?," Health Policy, Elsevier, vol. 80(1), pages 86-96, January.
- Ricardo Arcaro & Cássia Rita Pereira da Veiga & Wesley Vieira da Silva & Claudimar Pereira da Veiga, 2021. "Attitude and Purchase Intention to Generic Drugs," IJERPH, MDPI, vol. 18(9), pages 1-16, April.
- Granlund, David & Rudholm, Niklas, 2008. "Consumer Loyalty in the Swedish Pharmaceuticals Market," HUI Working Papers 17, HUI Research.
- Angelo Corallo & Maria Elena Latino & Biagio Nuzzo & Fabrizio Striani, 2025. "Advertising increases demand for the equivalent drugs: a theoretical model," SN Business & Economics, Springer, vol. 5(5), pages 1-19, May.
- Kanavos, Panos G. & Vandoros, Sotiris, 2011.
"Determinants of branded prescription medicine prices in OECD countries,"
Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
- Kanavos, Panos & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," LSE Research Online Documents on Economics 36351, London School of Economics and Political Science, LSE Library.
- Reinhard Busse & Tom Stargardt & Jonas Schreyögg, 2005. "Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(1), pages 30-36, November.
- Jörgen Hellström & Niklas Rudholm, 2010. "Uncertainty in the generic versus brand name prescription decision," Empirical Economics, Springer, vol. 38(3), pages 503-521, June.
- Herr, Annika, 2012. "Rationalisierung und Wettbewerb im Arzneimittelmarkt," DICE Ordnungspolitische Perspektiven 31, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
- Herr, Annika & Stühmeier, Torben & Wenzel, Tobias, 2014. "Reference pricing and cost-sharing: Theory and evidence on German off-patent drugs," VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy 100556, Verein für Socialpolitik / German Economic Association.
- Suppliet, Moritz & Herr, Annika, 2016.
"Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets,"
Discussion Paper
2016-040, Tilburg University, Center for Economic Research.
- Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 4d692f0e-8577-4392-b413-2, Tilburg University, School of Economics and Management.
- Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
- Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Discussion Paper 2016-021, Tilburg University, Tilburg Law and Economic Center.
- Matteo Galizzi & Simone Ghislandi & Marisa Miraldo, 2011. "Effects of Reference Pricing in Pharmaceutical Markets," PharmacoEconomics, Springer, vol. 29(1), pages 17-33, January.
- Annika Herr & Torben Stühmeier & Tobias Wenzel, 2023. "More cost‐sharing, less cost? Evidence on reference price drugs," Health Economics, John Wiley & Sons, Ltd., vol. 32(2), pages 413-435, February.
- Herr, A. & Suppliet, M., 2011.
"Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany,"
Health, Econometrics and Data Group (HEDG) Working Papers
11/18, HEDG, c/o Department of Economics, University of York.
- Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Discussion Paper 2016-021, Tilburg University, Tilburg Law and Economic Center.
- Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Discussion Paper 2016-040, Tilburg University, Center for Economic Research.
- Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
- Izabela Jelovac, 2015.
"On the relationship between the negotiated prices of pharmaceuticals and the patients' co-payment,"
Economics Bulletin, AccessEcon, vol. 35(1), pages 481-493.
- Izabela Jelovac, 2010. "On the relationship between the negociated price of pharmaceuticals and the patients' co-payment," Post-Print halshs-00588703, HAL.
- Izabela Jelovac, 2015. "On the relationship between the negociated price of pharmaceuticals and the patients' co-payment," Post-Print halshs-01089720, HAL.
- Vogler, Sabine & Habimana, Katharina & Arts, Danielle, 2014. "Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries," Health Policy, Elsevier, vol. 117(3), pages 311-327.
- Sabrina Terrizzi & Chad Meyerhoefer, 2020. "Estimates Of The Price Elasticity Of Switching Between Branded And Generic Drugs," Contemporary Economic Policy, Western Economic Association International, vol. 38(1), pages 94-108, January.
- Andrea Cintolesi & Andrea Riganti, 2022. "Liberalizing the opening of new pharmacies and hospitalizations," Temi di discussione (Economic working papers) 1388, Bank of Italy, Economic Research and International Relations Area.
- Seema Kacker & Tin Aung & Dominic Montagu & David Bishai, 2021. "Providers preferences towards greater patient health benefit is associated with higher quality of care," International Journal of Health Economics and Management, Springer, vol. 21(3), pages 271-294, September.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0023946. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.